Alkermes to Take Part in the Citi Annual BioPharma Virtual Conference

Rhea-AI Summary

Dublin-based Alkermes plc (Nasdaq: ALKS) announced participation in the Citi 16th Annual BioPharma Virtual Conference on September 9, 2021, at 8:50 a.m. ET. The management will engage in a fireside chat during the event, which will be accessible via the Investors tab on their website. The presentation will be available for 14 days post-event. Alkermes focuses on developing innovative medicines for neuroscience and oncology and has a portfolio that includes products for addiction, schizophrenia, and bipolar disorder.

Positive

• Participation in a reputable industry conference enhances visibility.
• Opportunities to engage with investors and stakeholders.

Negative

• None.

DUBLIN, Sept. 2, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Citi 16^th Annual BioPharma Virtual Conference on Thursday, Sept. 9, 2021 at 8:50 a.m. ET (1:50 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-citi-annual-biopharma-virtual-conference-301368052.html

SOURCE Alkermes plc

FAQ

What is the date of Alkermes' participation in the Citi BioPharma Virtual Conference?

Alkermes will participate in the Citi 16th Annual BioPharma Virtual Conference on September 9, 2021.

What time is Alkermes' presentation at the conference?

Alkermes' presentation is scheduled for 8:50 a.m. ET on September 9, 2021.

Where can I access Alkermes' presentation from the conference?

The presentation can be accessed under the Investors tab on Alkermes' website at www.alkermes.com.

How long will Alkermes' conference presentation be available for viewing?

The presentation will be archived and available for 14 days after the event.

What therapeutic areas does Alkermes focus on?

Alkermes develops innovative medicines in neuroscience and oncology, particularly for addiction, schizophrenia, and bipolar I disorder.